Acceleron Pharma Inc.
Extract: Update, Other Material Defense/Proxy Disclosure from a SC 14D9/A on 11/17/2021   Download
SEC Document
SEC Filing
Item 4. The Solicitation or Recommendation.

 

Item 4 of the Schedule 14D-9 is hereby amended and supplemented as follows:

 

Reasons

On November 17, 2021, the Filing Persons issued a press release (the “November 17 Press Release”) expressing their views on the Tender Offer, a copy of which is filed as Exhibit 4 hereto and incorporated by reference herein.